Quantinuum revenue and financials
$27.74Change from previous close: −0.79%Absolute change: −$0.22
In the fiscal year ended December 2025, Quantinuum reported revenue of $30.93M (+34.61% year over year). The net loss was $192.56M.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +34.61%
- 2025 vs 2024
- Net margin
- -622.6%
- 2024: -627.0%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 |
|---|---|---|
| Total revenue | 30.9 | 23.0 |
| Cost of revenue | 4.7 | 10.8 |
| Gross profit | 26.2 | 12.2 |
| Selling, general and administrative | 48.7 | 31.3 |
| Research and development | 165 | 122 |
| Operating income | -199 | -153 |
| EBIT | -199 | -153 |
| EBITDA | -170 | -121 |
| Pre-tax income | -192 | -144 |
| Income tax | 0.1 | 0.2 |
| Net income | -193 | -144 |
| Net income to common shareholders | -193 | -144 |
| Basic EPS | -0.64 | -0.48 |
| Diluted EPS | -0.64 | -0.48 |
| Average shares (basic) | 300 | 300 |
| Average shares (diluted) | 300 | 300 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Total revenue | 8.0 | 5.2 | 2.1 | 19.1 |
| Cost of revenue | 10.3 | 1.1 | 1.2 | 1.5 |
| Gross profit | -2.3 | 4.1 | 0.9 | 17.6 |
| Selling, general and administrative | 181 | 22.4 | 9.5 | 8.9 |
| Research and development | 367 | 54.7 | 39.7 | 35.8 |
| Operating income | -555 | -77.2 | -51.1 | -29.9 |
| EBIT | -555 | -77.2 | -51.1 | -29.9 |
| EBITDA | -546 | -68.2 | -43.6 | -22.5 |
| Pre-tax income | -596 | -137 | -56.9 | -30.3 |
| Income tax | 0.6 | 0.0 | 0.0 | 0.2 |
| Net income | -597 | -137 | -56.9 | -30.5 |
| Net income to common shareholders | -65.4 | 0.0 | -56.9 | -30.5 |
| Basic EPS | -1.93 | -0.48 | -1.64 | -0.10 |
| Diluted EPS | -1.93 | -0.48 | -1.64 | -0.10 |
| Average shares (basic) | 33.9 | 33.9 | 34.7 | 300 |
| Average shares (diluted) | 33.9 | 33.9 | 34.7 | 300 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 |
|---|---|---|
| Total assets | 1,846 | 1,070 |
| Current assets | 802 | 199 |
| Cash and equivalents | 763 | 172 |
| Short-term investments | 5.8 | 0.0 |
| Receivables | 19.1 | 13.0 |
| Net property, plant and equipment | 131 | 80.0 |
| Goodwill | 785 | 730 |
| Other intangible assets | 116 | 52.8 |
| Long-term investments | 10.1 | 0.0 |
| Current liabilities | 56.3 | 30.9 |
| Accounts payable | 11.9 | 8.9 |
| Total debt | 10.5 | 7.6 |
| Total liabilities | 158 | 71.7 |
| Total equity (incl. minority) | 1,688 | 999 |
| Retained earnings | -745 | -552 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|
| Total assets | 3,230 | 1,786 | — |
| Current assets | 2,149 | 720 | — |
| Cash and equivalents | 2,107 | 677 | — |
| Short-term investments | 5.8 | 5.8 | — |
| Receivables | 16.5 | 18.1 | — |
| Net property, plant and equipment | 182 | 160 | — |
| Goodwill | 770 | 774 | — |
| Other intangible assets | 105 | 109 | — |
| Long-term investments | 7.2 | 8.7 | — |
| Current liabilities | 139 | 65.2 | — |
| Accounts payable | 29.4 | 19.6 | — |
| Total debt | 32.7 | 24.8 | — |
| Total liabilities | 225 | 246 | — |
| Total equity (incl. minority) | 3,005 | 1,540 | 999 |
| Retained earnings | -65.4 | -881 | — |
| Minority interest | 2,592 | 2,818 | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 |
|---|---|---|
| Operating cash flow | -160 | -121 |
| Depreciation and amortization | 29.5 | 31.4 |
| Capital expenditure | -65.1 | -14.0 |
| Investing cash flow | -75.1 | -14.0 |
| Financing cash flow | 825 | 141 |
| Effect of exchange rates | 0.8 | -0.6 |
| Net change in cash | 590 | 5.1 |
| Free cash flow | -225 | -135 |
| Levered free cash flow | -158 | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Operating cash flow | -66.2 | -62.9 | -33.0 | -32.7 |
| Depreciation and amortization | 9.5 | 8.9 | 7.5 | 7.4 |
| Capital expenditure | -16.5 | -22.7 | -22.3 | -15.4 |
| Investing cash flow | -16.5 | -22.7 | -22.3 | -15.4 |
| Financing cash flow | 1,513 | 0.0 | 0.0 | 0.0 |
| Effect of exchange rates | -0.9 | -0.1 | -0.7 | 0.8 |
| Net change in cash | 1,430 | -85.6 | -56.1 | -47.4 |
| Free cash flow | -82.7 | -85.6 | -55.3 | -48.2 |
| Levered free cash flow | -280 | 391 | — | — |
Financial statements of similar companies
Companies in the group: same industry, similar size
